Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Claudio Campa"'
Autor:
Stefania Bigoni, Marcella Neri, Chiara Scotton, Roberto Farina, Patrizia Sabatelli, Chongyi Jiang, Jianguo Zhang, Maria Sofia Falzarano, Rachele Rossi, Davide Ognibene, Rita Selvatici, Francesca Gualandi, Dieter Bosshardt, Paolo Perri, Claudio Campa, Francesco Brancati, Marco Salvatore, Maria Chiara De Stefano, Domenica Taruscio, Leonardo Trombelli, Mingyan Fang, Alessandra Ferlini
Publikováno v:
Frontiers in Genetics, Vol 9 (2019)
Only a few genes involved in teeth development and morphology are known to be responsible for tooth abnormalities in Mendelian-inherited diseases. We studied an inbred family of Pakistani origin in which two first-cousin born brothers are affected by
Externí odkaz:
https://doaj.org/article/8cca511bd15c49fc80252eb81cd72c0d
Autor:
Cesare Furlanello, Katia De Nadai, Giuseppe Jurman, Francesco Sorrentino, Francesco Parmeggiani, Claudio Campa
Publikováno v:
Current Drug Targets. 21:1208-1215
Retinal diseases affect an increasing number of patients worldwide because of the aging population. Request for diagnostic imaging in ophthalmology is ramping up, while the number of specialists keeps shrinking. Cutting-edge technology embedding arti
Autor:
Claudio Campa
Publikováno v:
Ophthalmology Journal. 5:46-50
Background: The aim of the study was to compare the visual acuity (VA) score obtained in both normal subjects and patients with different eye diseases by using TOPCON CP-22 electronic ETDRS charts (i.e. E-ETDRS) and standard ETDRS charts (S-ETDRS). M
Autor:
Francesca Gualandi, Claudio Campa, Ilaria Passerini, Rossella Spena, Davide Ognibene, Francesco Parmeggiani
Publikováno v:
European Journal of Ophthalmology. 31:NP93-NP95
Purpose To describe a new genetic variation of BEST1 gene in Best vitelliform macular dystrophy. Methods A patient with bilateral multiple retinal yellowish lesions at the posterior pole underwent fluorescein angiography, fundus autofluorescence, opt
Autor:
Claudio Campa
Publikováno v:
Journal of the neurological sciences. 416
Autor:
Claudio Campa
Publikováno v:
Current drug targets. 21(12)
This review focuses on 5 new anti-VEGF drugs in the advanced stage of clinical development (i.e., phase 3): conbercept, brolucizumab, port delivery system with ranibizumab, abicipar pegol and faricimab. : Results of clinical trials and the advantages
Autor:
Claudio Campa, Ciro Costagliola, Carlo Incorvaia, Carl Sheridan, Francesco Semeraro, Katia De Nadai, Adolfo Sebastiani, Francesco Parmeggiani
Publikováno v:
Mediators of Inflammation, Vol 2010 (2010)
Choroidal neovascularization (CNV) is a common and severe complication in heterogeneous diseases affecting the posterior segment of the eye, the most frequent being represented by age-related macular degeneration. Although the term may suggest just a
Externí odkaz:
https://doaj.org/article/4b0e966a32cf4714a897ad14340ef831
Publikováno v:
Current Eye Research. 43:362-367
To evaluate the incidence of pseudophakic cystoid macular edema (PCMO) in patients treated with corticosteroids alone or in combination with bromfenac or nepafenac eyedrops after uneventful cataract surgery.Prospective, randomized, open-label, placeb
Publikováno v:
Current Drug Targets. 21:1158-1158
Effect of VEGF and anti-VEGF Compounds on Retinal Pigment Epithelium Permeability: An in Vitro Study
Autor:
Claudio Campa
Publikováno v:
European Journal of Ophthalmology. 23:690-696
To evaluate the effect of 2 vascular endothelial growth factor (VEGF) isoforms (121 and 165) and 2 anti-VEGF compounds (ranibizumab and pegaptanib sodium) on the permeability of human retinal pigment epithelium (RPE) cells in vitro. The RPE permeabil